DOH Announces Temporary Changes to Medical Marijuana Program to Assist Cardholders During COVID-19

HARRISBURG – The Pennsylvania Department of Health today announced that in light of the COVID-19 outbreak in Pennsylvania, the department is taking steps to assist those who need this form of medication.

“In the midst of COVID-19, we need to ensure medical marijuana patients have access to medication,” Secretary of Health Dr. Rachel Levine said.

“Medical marijuana grower/processors and dispensaries are considered life-sustaining businesses under the governor’s order for non-life-sustaining businesses to close. We want to be sure cardholders in the medical marijuana program can receive medication for one of 23 serious medical conditions during this difficult time.”

As of March 20, state officials say that certain statutory and regulatory provisions have been temporarily suspended in order to implement the following changes in response to the COVID-19 emergency:

The statutory and regulatory suspensions will remain in place for as long as the Proclamation of Disaster Emergency is in effect.

Statewide, state officials say that there are 268 cases of COVID-19 reported from commercial, hospital and state labs. There are 2,574 patients who have tested negative, and one death.

With commercial labs being the primary testing option for most Pennsylvanians, state officials emphasize that data is not available on the total number of tests pending.

Statewide, the Wolf Administration has announced:

The Wolf Administration stresses the role Pennsylvanians play in helping to reduce the spread of COVID-19:

Exit mobile version